Evidence map›Paper›PMID 30425153›Full record

ArticlemBio2018

Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.

Ambra Sarracino, Lavina Gharu, Anna Kula, Alexander O Pasternak, Veronique Avettand-Fenoel, Christine Rouzioux, Maryana Bardina, Stéphane De Wit, Monsef Benkirane, Ben Berkhout and 2 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 41 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. HibeRNAtion: HIV-1 RNA Metabolism and Viral Latency.Frontiers in cellular and infection microbiology · 2022
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 5 countries.

Ambra Sarracino *Laboratory of Molecular Virology, The International Center for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.
Lavina Gharu *Laboratory of Molecular Virology, The International Center for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.
Anna KulaInstitute for Molecular Biology and Medicine (IBMM), University of Brussels (ULB), Brussels, Belgium.
Alexander O PasternakLaboratory of Experimental Virology, Department of Medical Microbiology, Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands.
Veronique Avettand-FenoelService de Virologie, Hôpital Necker-Enfants-Malades, Université Paris-Descartes, EA7327, AP-HP, Paris, France.
Christine RouziouxService de Virologie, Hôpital Necker-Enfants-Malades, Université Paris-Descartes, EA7327, AP-HP, Paris, France.
Maryana BardinaLaboratory of Molecular Virology, The International Center for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.
Stéphane De WitService des Maladies Infectieuses, CHU St-Pierre, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Monsef BenkiraneLaboratory of Molecular Virology, Institute of Human Genetics, Montpellier, France.
Ben BerkhoutLaboratory of Experimental Virology, Department of Medical Microbiology, Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands.
Carine Van LintInstitute for Molecular Biology and Medicine (IBMM), University of Brussels (ULB), Brussels, Belgium.
Alessandro MarcelloLaboratory of Molecular Virology, The International Center for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy marcello@icgeb.org.ORCID 0000-0002-8903-8202
International Centre for Genetic Engineering and Biotechnology · ITAmsterdam UMC Location University of Amsterdam · NLHôpital Necker-Enfants Malades · FRInstitut de Génétique Humaine · FRJagiellonian University · PLUniversité Libre de Bruxelles · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Posttranscriptional regulation of HIV-1 replication is finely controlled by viral and host factors. Among the former, Rev controls the export of partially spliced and unspliced viral RNAs from the nucleus and their translation in the cytoplasm or incorporation into new virions as genomic viral RNA. To investigate the functional role of the Rev cofactor MATR3 in the context of HIV infection, we modulated its expression in Jurkat cells and primary peripheral blood lymphocytes (PBLs). We confirmed that MATR3 is a positive regulator of HIV-1 acting at a posttranscriptional level. By applying the same approach to J-lat cells, a well-established model for the study of HIV-1 latency, we observed that MATR3 depletion did not affect transcriptional reactivation of the integrated provirus, but caused a reduction of Gag production. Following these observations, we hypothesized that MATR3 could be involved in the establishment of HIV-1 posttranscriptional latency. Indeed, mechanisms acting at the posttranscriptional level have been greatly overlooked in favor of transcriptional pathways. MATR3 was almost undetectable in resting PBLs, but could be promptly upregulated upon cellular stimulation with PHA. However, HIV latency-reversing agents were poor inducers of MATR3 levels, providing a rationale for their inability to fully reactivate the virus. These data have been confirmed

Indexed as

Gene Expression Regulation, ViralRNA Processing, Post-TranscriptionalCD4-Positive T-LymphocytesGene ExpressionHIV-1HIV InfectionsHost Microbial InteractionsHumansJurkat CellsNuclear Matrix-Associated ProteinsRNA-Binding ProteinsRNA, ViralTHP-1 CellsVirus ActivationVirus LatencyMATR3 protein, humanNuclear Matrix-Associated ProteinsRNA-Binding ProteinsRNA, ViralHIV-1human immunodeficiency viruslatencylatency-reverting agentsLRAMATR3posttranscriptionposttranscriptional control mechanismsreservoirRNARNA binding proteinsshock and kill

Identifiers

PMID30425153
PMCPMC6234869
OpenAlexW2901483227

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.